Vascular endothelial growth factor and enhanced angiogenesis do not promote metastatic conversion of a newly established azoxymethane-induced colon cancer cell line

Molecular Carcinogenesis

Volumn 43, Issue 2, 2005, Pages 65-74

  Belinsky, Glenn S ^a   Claffey, Kevin P ^a   Nambiar, Prashant R ^a   Guda, Kishore ^a   Rosenberg, Daniel W ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b Center for Molecular Medicine   (United States)

Author keywords

Adenocarcinoma; Carcinogen; Mouse; Tumor

Indexed keywords

AZOXYMETHANE; CARCINOGEN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GRAFT; CANCER INHIBITION; CANCER INVASION; CARCINOMA IN SITU; COLON ADENOCARCINOMA; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; EPIGENETICS; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; MALE; METASTASIS; METASTASIS INHIBITION; MICROENVIRONMENT; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; ANTIGENS, CD31; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; KARYOTYPING; MALE; MICE; MICE, INBRED A; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE; MUS MUSCULUS;

EID: 20344403056     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.20079     Document Type: Article

References (35)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
2. Delker DA, Wang QS, Papanikolaou A, Whiteley HE, Rosenberg DW. Quantitative assessment of azoxymethane-induced aberrant crypt foci in inbred mice. Exp Mol Pathol 1999;65:141-149.
3. Papanikolaou A, Wang QS, Delker DA, Rosenberg DW. Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility. Cancer Lett 1998;130:29-34.
4. Druckrey E. Organ-specific carcinogenesis in the digestive tract. In: Nakahara TS, ST W, Odashima S, editor. Topics in chemical carcinogenesis. Baltimore, MD: University Park Press; 1972. pp 73-101.
5. Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW. Defective processing of the transforming growth factor-beta 1 in azoxymethane-induced mouse colon tumors. Mol Carcinog 2003;37:51-59.
6. Nambiar PR, Giardina C, Guda K, Aizu W, Raja R, Rosenberg DW. Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model. Cancer Res 2002;62:3667-3674.
7. Guda K, Giardina C, Nambiar P, Cui H, Rosenberg DW. Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors. Mol Carcinog 2001;31:204-213.
8. Papanikolaou AWQ, Papanikolaou D, Whiteley HE, Rosenberg DW. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Carcinogenesis 2000;21:1567-1572.
9. Nambiar PR, Girnun G, Lillo NA, Guda K, Whiteley HE, Rosenberg DW. Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. Int J Oncol 2003;22:145-150.
10. Detmar M, Velasco P, Richard L, et al. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am J Pathol 2000;156:159-167.
11. Shih SC, Mullen A, Abrams K, Mukhopadhyay D, Claffey KP. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells. J Biol Chem 1999;274:15407-15414.
12. Brunk UTTA. Lipofuscin: Mechanisms of age-related accumulation and influence on cell function. Radic Biol Med 2002;33:611-619.
13. Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002;20:4368-4380.
14. Guda K, Upender MB, Belinsky G, et al. Carcinogen-induced colon tumors in mice are chromosomally stable and are characterized by low-level microsatellite instability. Oncogene 2004;23:3813-3821.
15. Hoffman RM. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic. Invest New Drugs 1999;17:343-359.
16. Kubota T. Metastatic models of human cancer xenografted in the nude mouse: The importance of orthotopic transplantation. J Cell Biochem 1994;56:4-8.
17. Radinsky R. Molecular mechanisms for organ-specific colon carcinoma metastasis. Eur J Cancer 1995;31A:1091-1095.
18. Fridman R, Kibbey MC, Royce LS, et al. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel. J Natl Cancer Inst 1991;83:769-774.
19. Bonfil RD, Vinyals A, Bustuoabad OD, et al. Stimulation of angiogenesis as an explanation of Matrigel-enhanced tumorigenidty. Int J Cancer 1994;58:233-239.
20. Zhao X, Feldman D. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinology 1993;132:1808-1814.
21. Schuetz EG, Li D, Omiecinski CJ, et al. Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J Cell Physiol 1988;134:309-323.
22. Sato N, Michaelides MC, Wallack MK. Characterization of tumorigenicity, mortality, metastasis, and splenomegaly of two cultured murine colon lines. Cancer Res 1981;41:2267-2272.
23. Brattain MG, Strobel-Stevens J, Fine D, Webb M, Sarrif AM. Establishment of mouse colonic carcinoma cell lines with different metastatic properties. Cancer Res 1980;40:2142-2146.
24. Russell RL, Cao D, Zhang D, Handschumacher RE, Pizzorno G. Uridine phosphorylase association with vimentin. Intracellular distribution and localization. J Biol Chem 2001;276:13302-13307.
25. Tsuruo T, Iida H, Naganuma K, Tsukagoshi S, Sakurai Y. Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug. Cancer Res 1983;43:808-813.
26. Corbett TH, Griswold DP, Jr., Roberts BJ, Peckham JC, Schabel FM, Jr. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 1975;35:2434-2439.
27. Brand MI, Casillas S, Dietz DW, Milsom JW, Vladisavljevic A. Development of a reliable colorectal cancer liver metastasis model. J Surg Res 1996;63:425-432.
28. Whitehead RH, Van Eeden PE, Noble MD, Ataliotis P, Jat PS. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc Natl Acad Sci USA 1993;90:587-591.
29. Cui HDM, Sadhu DN, Rosenberg DW. Suppression of kinesin expression disrupts adenomatous polyposis coli (APC) localization and affects beta-catenin turnover in young adult mouse colon (YAMC) epithelial cells. Exp Cell Res 2002;280:12-23.
30. Claffey KP, Brown LF, del Aguila LF, et al. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996;56:172-181.
31. Kondo Y, Arii S, Mori A, Furutani M, Chiba T, Imamura M. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line. Clin Cancer Res 2000;6:622-630.
32. Ellis LM, Takahashi Y, Liu W, Shaheen RM. Vascular endothelial growth factor in human colon cancer: Biology and therapeutic implications. Oncologist 2000;5:11-15.
33. Bruns CJ, Liu W, Davis DW, et al. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 2000;89:488-499.
34. Shaheen RM, Tseng WW, Vellagas R, et al. Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis. Int J Oncol 2001;18:221-226.
35. Nakata S, Ito K, Fujimori M, et al. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers. Int J Cancer 1998;79:179-186.